A reversed-phase high performance liquid chromatography method using solid phase extraction to quantitate thalidomide in human serum
- 1 February 1997
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 339 (1-2), 91-97
- https://doi.org/10.1016/s0003-2670(96)00494-1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Determination of thalidomide by high performance liquid chromatography: Methodological strategy for clinical trialsClinical Biochemistry, 1995
- High-Performance Liquid Chromatographic Assay of Plasma Thalidomide: Stabilization of Specimens and Determination of a Tentative Therapeutic Range for Chronic Graft-Versus-Host DiseaseAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1995
- Rapid and Sensitive Determination of Thalidomide in Human Plasma by High Performance Liquid ChromatographyJournal of Liquid Chromatography, 1995
- Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradationJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditionsJournal of the American Academy of Dermatology, 1982
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971
- IMMUNOSUPPRESSION BY THALIDOMIDE: IMPLICATIONS FOR TERATOLOGYThe Lancet, 1966
- The Saga of ThalidomideNew England Journal of Medicine, 1962